Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harald Hampel

Showing results (101-110 of 411) with videos related to

Pageof 42
Sort By:
Clinical Practice and Epidemiology in Mental Health : CP & EMH|June 18, 2009
Anticonvulsants in the treatment of aggression in the demented elderly: an updateBenedikt Amann, Johannes Pantel, Heinz Grunze, et al.
Brain : a Journal of Neurology|February 27, 2004
Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometryStefan J Teipel, Gene E Alexander, Marc B Schapiro, et al.
Journal of Alzheimer'S Disease : JAD|March 1, 2016
Performance of Hippocampus Volumetry with FSL-FIRST for Prediction of Alzheimer's Disease Dementia in at Risk Subjects with Amnestic Mild Cognitive ImpairmentPer Suppa, Harald Hampel, Timo Kepp, et al.
Neuromolecular Medicine|September 21, 2016
Cerebrospinal Fluid Stanniocalcin-1 as a Biomarker for Alzheimer's Disease and Other Neurodegenerative DisordersPashtun Shahim, Kaj Blennow, Per Johansson, et al.
Trends in Neurosciences|January 15, 2023
The foundation and architecture of precision medicine in neurology and psychiatryHarald Hampel, Peng Gao, Jeffrey Cummings, et al.
Expert Review of Molecular Diagnostics|June 11, 2019
Blood-based diagnostics of Alzheimer's diseaseGregory Penner, Soizic Lecocq, Anaëlle Chopin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 22, 2017
Free and Cued Selective Reminding Test - accuracy for the differential diagnosis of Alzheimer's and neurodegenerative diseases: A large-scale biomarker-characterized monocenter cohort study (ClinAD)Marc Teichmann, Stéphane Epelbaum, Dalila Samri, et al.
Brain : a Journal of Neurology|March 13, 2008
Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's diseaseMichael Ewers, Zhenyu Zhong, Katharina Bürger, et al.
Med (New York, N.Y.)|September 10, 2024
Fluid biomarkers in the context of amyloid-targeting disease-modifying treatments in Alzheimer's diseaseYan Hu, Min Cho, Pallavi Sachdev, et al.
Psychophysiology|September 6, 2002
Value of event-related P300 subcomponents in the clinical diagnosis of mild cognitive impairment and Alzheimer's DiseaseThomas Frodl, Harald Hampel, Georg Juckel, et al.
Pageof 42

Showing results (101-110 of 411) with videos related to

Sort By:
Pageof 42
Clinical Practice and Epidemiology in Mental Health : CP & EMH|June 18, 2009
Anticonvulsants in the treatment of aggression in the demented elderly: an updateBenedikt Amann, Johannes Pantel, Heinz Grunze, et al.
Brain : a Journal of Neurology|February 27, 2004
Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometryStefan J Teipel, Gene E Alexander, Marc B Schapiro, et al.
Journal of Alzheimer'S Disease : JAD|March 1, 2016
Performance of Hippocampus Volumetry with FSL-FIRST for Prediction of Alzheimer's Disease Dementia in at Risk Subjects with Amnestic Mild Cognitive ImpairmentPer Suppa, Harald Hampel, Timo Kepp, et al.
Neuromolecular Medicine|September 21, 2016
Cerebrospinal Fluid Stanniocalcin-1 as a Biomarker for Alzheimer's Disease and Other Neurodegenerative DisordersPashtun Shahim, Kaj Blennow, Per Johansson, et al.
Trends in Neurosciences|January 15, 2023
The foundation and architecture of precision medicine in neurology and psychiatryHarald Hampel, Peng Gao, Jeffrey Cummings, et al.
Expert Review of Molecular Diagnostics|June 11, 2019
Blood-based diagnostics of Alzheimer's diseaseGregory Penner, Soizic Lecocq, Anaëlle Chopin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 22, 2017
Free and Cued Selective Reminding Test - accuracy for the differential diagnosis of Alzheimer's and neurodegenerative diseases: A large-scale biomarker-characterized monocenter cohort study (ClinAD)Marc Teichmann, Stéphane Epelbaum, Dalila Samri, et al.
Brain : a Journal of Neurology|March 13, 2008
Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's diseaseMichael Ewers, Zhenyu Zhong, Katharina Bürger, et al.
Med (New York, N.Y.)|September 10, 2024
Fluid biomarkers in the context of amyloid-targeting disease-modifying treatments in Alzheimer's diseaseYan Hu, Min Cho, Pallavi Sachdev, et al.
Psychophysiology|September 6, 2002
Value of event-related P300 subcomponents in the clinical diagnosis of mild cognitive impairment and Alzheimer's DiseaseThomas Frodl, Harald Hampel, Georg Juckel, et al.
Pageof 42